中国上市药品目录集

《中国上市药品目录集》是由国家食品药品监督管理总局组织制定的药品信息数据库，收录具有安全性、有效性和质量可控性的药品，并确定参比制剂和标准制剂。该数据库以网络版形式发布并实时更新，提供药品名称等关键词查询功能，每年末发布电子版供公众下载。数据库旨在促进药物研发创新，提高仿制药质量，明确仿制药标准，并为建立药品专利链接制度提供支持。"China Approved Drug Products Directory" is a pharmaceutical information database developed and organized by the National Food and Drug Administration of China. It collects drugs that have demonstrated safety, efficacy and controllable quality, and identifies reference listed drugs (RLD) and standard preparations. This database is released in a web-based version with real-time updates, provides keyword search functions such as drug names, and publishes an electronic version for public download at the end of each year. The database aims to promote pharmaceutical research and innovation, improve the quality of generic drugs, clarify the standards for generic medications, and provide support for the establishment of a drug patent linkage system.

搜集汇总

背景与挑战

背景概述

中国上市药品目录集是由国家药品监督管理局（原国家食品药品监督管理总局）制定的官方药品信息数据库，收录具有安全性、有效性和质量可控性的药品，并明确参比制剂和标准制剂。该数据库以网络版形式实时更新，提供药品名称等关键词查询功能，每年末发布电子版供公众下载，旨在促进药物研发创新、提高仿制药质量并支持药品专利链接制度的建立。